BioMarin Pharmaceuticals BMRN Income Tax
Income Tax at other companies
Other financials
Where this comes from
Reported directly by BioMarin Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.
The official record: BioMarin Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioMarin Pharmaceuticals's income tax.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioMarin Pharmaceuticals's income tax?
- BioMarin Pharmaceuticals (BMRN) reported income tax of $35.68M in Q1 2026.
- How has BioMarin Pharmaceuticals's income tax changed year-over-year?
- BioMarin Pharmaceuticals's income tax decreased by 31.9% year-over-year, from $52.4M to $35.68M.
- What is the long-term trend for BioMarin Pharmaceuticals's income tax?
- Over 3 years (2021 to 2025), BioMarin Pharmaceuticals's income tax has grown at a 128.0% compound annual growth rate (CAGR), from -$11.27M to $133.58M.
- What does income tax mean?
- The total amount of tax a company owes on its earnings for the period.
- How do you interpret income tax?
- An increase usually tracks with higher profitability, though it can also be affected by changes in tax legislation or accounting adjustments.
- How does income tax compare across companies?
- Varies significantly based on the company's geographic footprint and tax strategy compared to industry peers.